跳至主要内容
临床试验/ACTRN12619001435178
ACTRN12619001435178已完成未知

The influence of medical companions on a patient’s hypothetical decision to switch to abiosimilar.

Professor Keith Petrie0 个研究点目标入组 79 人开始时间: 2019年10月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
79

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients are eligible to participate if they:
  • - are attending an appointment with their rheumatologist/dermatologist at a clinic across the Auckland and Waitemata District Health Board,
  • - are 18 years of age or over,
  • - take a biologic medication (e.g., adalimumab, etanercept, infliximab, rituximab, tocilizumab),
  • - have a companion (support person) that is 18 years of age or over.

排除标准

  • Participants will be excluded from this study if they:
  • - are unable to fill out the questionnaires,
  • - cannot understand, read or write English.

研究者

发起方
Professor Keith Petrie

相似试验